Results 11 to 20 of about 491,703 (337)
Outcomes of Enhanced Recovery after Surgery (ERAS) in Gynecologic Oncology: A Review
Enhanced Recovery After Surgery (ERAS) is a global surgical quality improvement program that started in colorectal surgery and has now expanded to numerous specialties, including gynecologic oncology.
Steven P. Bisch, Gregg Nelson
doaj +2 more sources
African women have double the risk of dying from cancer than women in high-income countries. In Ghana, most women with gynecological malignancies present with advanced-stage disease when treatment is less effective.
Anna Sarah Erem+11 more
doaj +2 more sources
Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment
The Japan Society of Gynecologic Oncology (JSGO) Guidelines 2022 for the Treatment of Uterine Cervical Cancer are revised from the 2017 guideline. This guideline aimed to provide standard care for cervical cancer, indicate appropriate current treatment ...
Manabu Seino+13 more
semanticscholar +1 more source
Participation of Patients With Limited English Proficiency in Gynecologic Oncology Clinical Trials.
BACKGROUND Significant disparities exist in recruitment of minorities to clinical trials, with much of the prior literature focused on race/ethnicity only. Limited English proficiency (LEP) is a known barrier in healthcare that may also drive disparities
S. Jorge+4 more
semanticscholar +1 more source
Enhanced Recovery after Surgery (ERAS) for Minimally Invasive Gynecologic Oncology Surgery: A Review
Enhanced recovery after surgery (ERAS) has established benefits in open gynecologic oncology surgery. However, the benefits for gynecologic oncology patients undergoing minimally invasive surgery (MIS) are less well defined. We conducted a review of this
Christa Aubrey, Gregg Nelson
doaj +1 more source
Gender imbalance in gynecologic oncology authorship and impact of COVID-19 pandemic
Objective Despite increased participation of women in academic medicine in recent decades, gender disparities persist. The gender gap in authorship and editorial boards in gynecologic oncology, and impact of the COVID-19 pandemic, have not been recently ...
S. Mah+5 more
semanticscholar +1 more source
Insurance-Mediated Disparities in Gynecologic Oncology Care
Insurance coverage has lagged behind improvements in gynecologic cancer care, with one third of women never seeing a gynecologic oncologist and half experiencing financial toxicity during cancer treatment. With 102,000 new cases of gynecologic cancer, 30,
Anna Jo Bodurtha Smith+2 more
semanticscholar +1 more source
PURPOSE The status of p53 in a tumor can be inferred by next-generation sequencing (NGS) or by immunohistochemistry (IHC). We examined the association between p53 IHC and sequence and whether p53 IHC alone, or integrated with TP53 NGS, predicts the ...
Kristina W. Thiel+15 more
semanticscholar +1 more source
Gynecologic oncology in pregnancy [PDF]
In this review current knowledge on prevalence, diagnosis, treatment and prognosis of gynaecological malignancies during pregnancy is discussed. After a general overview of surgery, chemotherapy and radiotherapy during pregnancy, tumor specific diagnosis and treatment options are described for breast, cervical, ovarian, endometrial and vulvar cancer ...
Amant, F.+3 more
openaire +3 more sources
Association of Distance to Gynecologic Oncologist and Survival in a Rural Midwestern State
Objectives: Rural ovarian cancer patients experience worse survival compared to urban patients. We assessed whether distance to gynecologic oncology specialists was associated with survival for patients in a rural state.
Keely K. Ulmer+5 more
doaj +1 more source